Related Experiment Video
Updated: Jul 4, 2026
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
MRI Predictors of Outcome in Primary Central Nervous System Lymphoma Patients Before and After Autologous Stem Cell
Dewen Meng1,2, Hamza Alshuft1, Christopher P Fox3,4
1Clinical Radiology Department Nottingham University Hospitals NHS Trust Nottingham UK.
Introduction:
Primary CNS lymphoma (PCNSL) is treated with intensive chemotherapy and autologous stem cell transplant (HDT-ASCT), yet up to one-third of patients relapse. Standard MRI response criteria may not reliably distinguish residual tumour from post-treatment change; additional MRI sequences, such as apparent diffusion coefficient (ADC), could assist in the determination of early relapses, although their prognostic value remains uncertain.
Methods:
We retrospectively analysed 63 PCNSL patients, assessed pre-HDT-ASCT IPCG response and ADC values, and examined associations with 2-year relapse-free survival.
Results:
Only pre-HDT-ASCT IPCG status, not the lesion ADC value, significantly predicted the 2-year outcome (p = 0.005). An overall CR rate of 85% was observed at a median follow-up of 24.7 months.
Conclusions:
Pre-HDT-ASCT IPCG status, not ADC values, predicts 2-year IPCG status in PCNSL patients.
